Economic consequence of immediate testing for C-reactive protein and leukocyte count in new outpatients with acute infection

The cost per antibiotic prescription reduced with advance testing was ¥604 (∼ US$5.8) in our clinical setting. Judicious use of antivirals and introduction of a simple CRP test kit would improve cost-effectiveness.